Intervention

Sarilumab

ClinicalTrials.gov intervention label

Clinical trials13

Recruiting2

Common conditions8

Lead sponsors shown6

Clinical trials

13 shown

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT07154290 · 2026-03-18

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseNCT03414502 · 2007-12-10

Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid ArthritisNCT04842981 · 2021-05-25

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) InhibitorsNCT04134728 · 2019-10-31

Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to BiologicsNCT03535402 · 2018-06-01

A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)NCT02373202 · 2015-02-01

Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)NCT02332590 · 2015-01-28

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisNCT02057250 · 2014-03-01

Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)NCT02097524 · 2014-03-01

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateNCT01764997 · 2013-04-01

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)NCT01709578 · 2012-10-01

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersNCT01217814 · 2010-11-01

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsNCT01061736 · 2010-03-01

Common conditions

Rheumatoid Arthritis9 Arthritis, Rheumatoid2 Advanced Non Small Cell Lung Cancer1 Carcinoma Non Small Cell Lung1 Interaction1 Metastatic Non Small Cell Lung Cancer1 Non Small Cell Lung Cancer1 RA1

Leading sponsors

Sanofi7 Regeneron Pharmaceuticals2 Gaylis, Norman B., M.D.1 GlaxoSmithKline1 University of Nebraska1 University of Southern Denmark1

Trial status mix

COMPLETED7

TERMINATED3

RECRUITING2

UNKNOWN1

Phase mix

PHASE39

PHASE24

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.